Tag: Investment Agenda

Insight as a Foundation: PharmaNL’s 4DMap and Gap Analysis
April 10, 2025

PharmaNL has set itself an ambitious goal: strengthening and future-proofing the pharmaceutical sector by optimizing both the infrastructure for drug development and the training opportunities. PharmaNL is doing this within two main program lines: Shared Development Infrastructure and Human Capital Growth. To accurately map out where the greatest needs and bottlenecks lie, PharmaNL conducts a […]

Opening PharmaNL SDI subsidy call on March 18, 2025
March 18, 2025

ZonMw, the subsidy administrator of PharmaNL, opens a subsidy call within the PharmaNL Shared Development Infrastructure program on Tuesday, March 18, 2025. The objective of this subsidy call is to address the prioritized themes from PharmaNL’s investment agenda. View this investment agenda, published on January 30, 2025, here. Read the full news article about the […]

investeringsagenda shared
PharmaNL publishes Investment Agenda for Shared Development Infrastructure
January 30, 2025

PharmaNL today publishes the Investment Agenda for the Shared Development Infrastructure program line. This document (part 3) is an integral part of the PharmaNL investment agenda as presented on August 22, 2024, focusing on the Human Capital Growth program line. The Investment Agenda serves as a roadmap for investments aimed at strengthening the Dutch pharmaceutical […]

PharmaNL Presents Investment Agenda: Roadmap for a Stronger Pharmaceutical Future
August 22, 2024

PharmaNL today publishes the PharmaNL Investment Agenda, a roadmap for targeted investments in educational opportunities to strengthen the Dutch pharmaceutical value chain. Based on a gap analysis and expert session, the Investment Agenda identifies key themes for future grant calls under the PharmaNL program. The next grant call will focus on the new funding round […]